Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs

GBI Research's latest report, "Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs", discusses global commercial trends and prospects for human medicines applied in the veterinary setting, also called crossover drugs. A wide range of human drugs continue to be applied in the veterinary space due to a lack of approved animal therapies, convenience and the rising costs of veterinary research.

This new report provides insights into Extra-label Drug Use (ELDU), its application in the veterinary setting and other guidelines and regulations followed by professionals in the animal health industry. Through a series of in-depth case studies this report provides insights into the rationale for the transition of several human drugs to the veterinary setting as well as disease overviews, competing treatments, manufacturer information, dosage forms, cost of therapy and other insightful marketing information. Our new study also identifies and explores important drivers and restraints of the crossover drugs market.

Full Report Details at
- http://www.fastmr.com/prod/1183631_human_drugs_for_veterinary.aspx?afid=301

Information leveraged from our robust industry-leading database shows a diverse range of marketed human drugs being used in companion animals especially cats, dogs and horses. Our new report includes detailed profiles of key animal health companies with diverse portfolios of crossover drugs as well as strategies being employed by competitors in this market to leverage human therapies into the veterinary space. Additionally, we identify emerging companies marketing various crossover drugs across a range of therapy areas.

GBI Research conducted extensive research in order to provide a comprehensive view of the current trends and commercial prospects for crossover drugs. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising commercial areas in the market and exploit key business opportunities.

Report Scope

What regulations need to be followed when prescribing human drugs off-label to pets and food-producing animals?
What are the main factors driving the prescription of human medicines in animals?
Marketed human drugs commonly used in companion animals
- What are the differences in indication between the human and veterinary setting?
- What are the dosage and side effects of those specific drugs in animals?
- Are there any existing and approved veterinary therapies for the same indication? Why is the human drug preferred over the approved animal drug?
- What are the key drivers and barriers that affect ELDU of human drugs in animals?
- What is currently restricting the crossover drugs market?
- What are the key animal health companies with prominent crossover drug portfolios?
Explore recent financial performance, crossover drugs brands, and the number of species supported through their animal health product portfolio

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
- Human Insulin Market - Forecasts to 2020
- PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2023
- OpportunityAnalyzer: Growth Hormone Deficiency - Opportunity Analysis and Forecast to 2024
- Dyslipidaemia: KOL Insight